
Opinion|Videos|February 28, 2024
Clinical Trial Landscape: KRYSTAL-7
Author(s)Hatim Husain, MD
Highlight key findings in the KRYSTAL-7 trial.
Advertisement
Episodes in this series

Advertisement
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
Dual BCMA/CD19 CAR T, AZD0120, Yields 96% ORR in Myeloma; Fast Turnaround
2
Linvoseltamab Monotherapy Effective in Newly Diagnosed Multiple Myeloma
3
NCCN Guidelines in nccRCC Weigh New Data for Combinations
4
Subcutaneous Cevostamab Shows Early Promise in R/R Myeloma
5







































